Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome. uri icon

Overview

publication date

  • September 1, 2014

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Drug Eruptions
  • Lymphohistiocytosis, Hemophagocytic
  • Sezary Syndrome
  • Skin Diseases
  • Skin Neoplasms

Identity

Scopus Document Identifier

  • 84908233314

Digital Object Identifier (DOI)

  • 10.1001/jamadermatol.2013.10615

PubMed ID

  • 25029560

Additional Document Info

volume

  • 150

issue

  • 9